NCT03446014
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +5 more
- Locations
-
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Peripheral Arterial Disease
Explore clinical trials studying Peripheral Arterial Disease. Study availability and eligibility vary by location and protocol.
960 public trials
152 recruiting studies
Peripheral Arterial Disease trial results
NCT03305198
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +5 more
- Locations
-
- Centre hospitalier universitaire Angers, France
NCT01319812
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +6 more
- Locations
-
- Fremont, California, United States
- New Haven, Connecticut, United States
- Washington D.C., District of Columbia, United States
- Rockford, Illinois, United States
NCT02371785
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +12 more
- Locations
-
- Medizinische Univeristät Graz Graz, Austria
NCT01241747
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +10 more
- Locations
-
- Clinical Research Center, Penn State College of Medicine Hershey, Pennsylvania, United States
NCT02066740
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +5 more
- Locations
-
- Klinikum Weiden Weiden, Germany
Completed
Edoxaban in Peripheral Arterial Disease
NCT01802775
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +4 more
- Locations
-
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Beverly Hills, California, United States
- Los Angeles, California, United States
NCT03844724
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +10 more
- Locations
-
Not specified
NCT02901847
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +4 more
- Locations
-
- Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom
Completed
Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)
NCT01679990
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
- Locations
-
- Cardiology, P. C. and Center for Therapeutic Angiogenesis Birmingham, Alabama, United States
- Tampa Bay Medical Research Clearwater, Florida, United States
- Florida Researc Network, LLC Gainesville, Florida, United States
- DMI Research Pinellas Park, Florida, United States